Language selection

Government of Canada / Gouvernement du Canada

Search

Guidance document : post-notice of compliance (NOC) changes : safety and efficacy document.: H164-271/2019E-PDF

"This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to section C.08.004 of the Food and Drug Regulations. These new drugs may include pharmaceuticals, biologics, and radiopharmaceuticals for human use and pharmaceutical and certain biotechnological products for veterinary use1, including those submissions for which a NOC has been recommended but issuance of the NOC has been placed on hold"--Introduction, page 6.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.867837&sl=0

Publication information
Department/Agency
  • Canada. Health Canada, issuing body.
TitleGuidance document : post-notice of compliance (NOC) changes : safety and efficacy document.
Variant title
  • Post‐NOC changes: safety & efficacy
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • "Publication date: July 2019."
  • "Date adopted: 2009/09/02; revised date: 2019/08/12; effective date: 2019/08/12."
  • Issued also in HTML format.
  • Issued also in French under title: Changements survenus après l’avis de conformité (AC) : document sur l’innocuité et l’efficacité.
Publishing information
  • Ottawa, ON : Health Canada = Santé Canada, 2019.
  • ©2019
Description1 online resource (20 pages)
ISBN9780660294506
Catalogue number
  • H164-271/2019E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: